Development and Role in Therapy of Canakinumab in Adult-Onset Still’s Disease

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2018.01074
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

Efficacy of Canakinumab as First-Line Biologic Agent in Adult-Onset Still’s Disease

Arthritis Research & Therapy
2019English

Delay in the Diagnosis of Adult-Onset Still’s Disease

Cureus
2017English

Anakinra for the Treatment of Adult-Onset Still’s Disease

Expert Review of Clinical Immunology
AllergyImmunology
2018English

Adult-Onset Still’s Disease in an Elderly Woman With Atypical Presentation

Case Reports in Internal Medicine
2014English

Adult-Onset Still’s Disease Presenting as an Atypical Cutaneous Eruption

SKIN The Journal of Cutaneous Medicine
2019English

Adult Onset Still’s Disease Masquerading as Acute Coronary Syndrome

International Journal of Diagnostic Imaging
2016English

Impaired Autophagic Flux and Its Related Inflammation in Patients With Adult-Onset Still’s Disease

Oncotarget
Oncology
2017English

Prurigo Pigmentosa-Like Persistent Papules and Plaques in a Patient With Adult-Onset Still’s Disease

Acta Dermato-Venereologica
DermatologyMedicine
2014English

Adult-Onset Still’s Disease Masquerading as Sepsis in an Asplenic Active Duty Soldier

Case Reports in Medicine
Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy